相关实验视频

Updated: Jun 17, 2025

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

喉神经瘤与与之并发的奥西默提尼布反应的第四阶段肺腺癌:一个说明性的案例

Shunya Kashiwagi¹, Masahiro Tanji¹, Toshiki Matsuoka¹

¹Departments of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Journal of neurosurgery. Case lessons

|August 12, 2024

概括

分子向药物可以改善癌症的预后. 这一案例突出显示,虽然奥西默提尼布治疗了肺腺癌,但同时发生的三角质神经瘤需要手术干预,强调对并发性脑瘤进行个性化治疗.

科学领域:

神经瘤学神经瘤学
胸部瘤学胸部瘤学
分子向疗法分子向疗法

背景情况:

分子向药物的进步改善了癌症患者的治疗结果.
个性化治疗对于内瘤至关重要,特别是当伴随性癌症存在时.

研究的目的:

报告一个同时患有肺腺癌和三神经神经瘤的病例.
讨论多种不同的瘤患者的管理挑战和治疗策略.

主要方法:

一名患有第四阶段肺腺癌和EGFR突变的患者接受了osimertinib治疗.
一个导致神经缺陷的内质被手术切除.
病理学检查证实了三神经的 schwannoma.

主要成果:

奥西默提尼布有效地减少了肺腺癌结节.
内 schwannoma 进展,导致水脑和神经症状需要手术干预.
通过手术切除瘤,导致神经症状有所改善.

结论:

奥西默提尼布对EGFR突变的肺腺癌有效,但对三神经神经瘤是不有效的.
癌症患者同时出现的良性脑瘤需要个性化治疗计划,通常包括手术干预.
在瘤学中,定制治疗对于管理并发性疾病至关重要. 在https://thejns.org/doi/10.3171/CASE24144.4.上可以看到.

关键词:

肺部腺癌瘤是什么?奥西米尔丁尼布 (osimertinib) 是一种三神经神经瘤 (Trochlear神经神经 schwannoma) 是一种神经瘤.

更多相关视频

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...